Abstract:Background and Objective: The dynamic assessment of disease activity during the follow-up of patients with Crohn’s disease (CD) remains a significant challenge. In this study, we aimed to identify the role of dynamic contrast-enhanced ultrasound (DCE-US) in the evaluation of activity of CD. Methods: In the retrospective study, patients diagnosed with CD in our hospital were included. All the diagnoses were confirmed by clinical symptoms and ileocolonoscopical results. All patients underwent intestinal ultrasound and contrast-enhanced ultrasound (CEUS) examinations within 1 week of the ileocolonoscopy examinations. Acuson Sequoia (Siemens Healthineers, Mountain View, CA, USA) and Resona R9 Elite (Mindray Medical Systems, China) with curved array and Line array transducers were used. The CEUS examination was performed with SonoVue (Bracco SpA, Milan, Italy). DCE-US analysis was performed by UltraOffice (version: 0.3-2010, Mindray Medical Systems, China) software. Two regions of interest (ROIs) were set in the anterior section of the infected bowel wall and its surrounding normal bowel wall 2 cm distant from the inflamed area. Time–intensity curves (TICs) were generated and quantitative perfusion parameters were obtained after curve fittings. The Simple Endoscopic Score for Crohn’s disease (SES-CD) was regarded as the reference standard to evaluate the activity of CD. The receiver operating characteristic curve (ROC) analyses were used to determine the diagnostic efficiency of DCE-US quantitative parameters. Results: From March 2023 to November 2023, 52 CD patients were included. According to SES-CD score, all patients were divided into active group with the SES-CD score > 5 (n = 39) and inactive group SES-CD score < 5 (n = 13). Most of the active CD patients showed bowel wall thickness (BWT) > 4.2 mm (97.4%, 38/39) or mesenteric fat hypertrophy (MFH) on intestinal ultrasound (US) scan (69.2%, 27/39). Color Doppler signal of the bowel wall mostly showed spotty or short striped blood flow signal in active CD patients (56.4%, 22/39). According to CEUS enhancement patterns, most active CD patients showed a complete hyperenhancement of the entire intestinal wall (61.5%, 24/39). The TICs of active CD showed an earlier enhancement, higher peak intensity, and faster decline. Among all CEUS quantitative parameters, amplitude-derived parameters peak enhancement (PE), wash-in area under the curve (WiAUC), wash-in rate (WiR), wash-in perfusion index (WiPI), and wash-out rate (WoR) were significantly higher in active CD than in inactive CD (p < 0.05). The combined AUROC of intestinal ultrasound features and DCE-US quantitative perfusion parameters in the diagnosis of active CD was 0.987, with 97.4% sensitivity, 100% specificity, and 98.1% accuracy. Conclusions: DCE-US with quantitative perfusion parameters is a potential useful noninvasive imaging method to evaluate the activity of Crohn’s disease.

Dynamic Contrast-Enhanced Endoscopic Ultrasound: A Quantification Method

EFSUMB Technical Review – Update 2023: Dynamic Contrast-Enhanced Ultrasound (DCE-CEUS) for the Quantification of Tumor Perfusion

3-D Quantitative Dynamic Contrast Ultrasound for Prostate Cancer Localization.

New endoscopic ultrasound techniques for digestive tract diseases: A comprehensive review.

Contrast-enhanced endoscopic ultrasonography: advance and current status

Preoperative T Staging of Advanced Gastric Cancer Using Double Contrast-Enhanced Ultrasound.

Double Contrast-Enhanced Ultrasonography in Preoperative Borrmann Classification of Advanced Gastric Carcinoma: Comparison with Histopathology

Enhancement Patterns Of Gastric Carcinoma On Contrast-Enhanced Ultrasonography: Relationship With Clinicopathological Features

Application of Contrast-Enhanced Ultrasound in Emergency and Critical Care Medicine

How to perform Contrast-Enhanced Ultrasound (CEUS)

Diagnostic Endoscopic Ultrasound: Technique, Current Status and Future Directions

Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver

History of contrast enhanced ultrasound (CEUS)

Application of Dynamic Contrast-Enhanced Ultrasound in Evaluation the Activity of Crohn's Disease

Dynamic contrast-enhanced MRI in oncology: how we do it

Contrast-enhanced ultrasound: The evolving applications

Application of Dynamic Contrast-Enhanced Ultrasound in Evaluation the Activity of Crohn’s Disease

VueBox (R) for quantitative analysis of contrast-enhanced ultrasound in liver tumors

Contrast-enhanced guided endoscopic ultrasound procedures

Ultrasound capsule endoscopy: sounding out the future

Contrast-enhanced US for the Interventional Radiologist: Current and Emerging Applications